Zensights Names Andrew Shales as Principal

Zensights LLC is pleased to announce that Andrew Shales has joined the organization as a principal. Shales is a proven leader in the pharmaceutical, medical device and diagnostic markets with a deep commercial background and broad organizational leadership experiences, including international, matrixed companies. Shales has launched or relaunched more than 25 ethical pharmaceutical brands. He also led four startup pharma organizations from inception through the multiple hurdles young pharma companies must navigate.

Shales is a welcome addition to the Zensights team and brings experience in modeling and strategic planning within companies of all sizes. In this new role, he will lead client engagements and support their growth using the Zensights multi-client product platforms and the company's Subject Matter Expert (SME) roster.

Bob Jansen, CEO of Zensights stated, "As the former leader of four emerging pharma companies, Andrew brings a very valuable perspective to our client base. His reputation in the industry is stellar and we are very excited to have him join the team."

About Zensights

Founded in 2012, Zensights is focused on helping BioPharma organizations improve business results by building relationships with "Best in Class" vendors on a "capability by capability" perspective. For pharmaceutical and biotech business leaders looking to optimize services using a new or existing vendor partner, Zensights provides software, advanced consulting, vetting, and executive connections to help commercial and procurement partners secure high-quality, fit-for-purpose, cost-effective contracts and solutions to drive business results.